C9073 is a valid 2023 HCPCS Code that could be used to indicate Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose for reimbursement purposes.
C9073 belongs to Other Medical Items or Services Type of Service and has been in effect since Jan 01, 2021.
Brexucabtagene autoleucel ca
C9073 code information
| HCPCS code: | C9073 |
| Description: | BREXUCABTAGENE AUTOLEUCEL, UP TO 200 MILLION AUTOLOGOUS ANTI-CD19 CAR POSITIVE VIABLE T CELLS, INCLUDING LEUKAPHERESIS AND DOSE PREPARATION PROCEDURES, PER THERAPEUTIC DOSE |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Jan 01, 2021 |
| Termination Date: | HCPCS C9073 was terminated on Nov 30, -0001 |
| Pricing indicator: | 53 - STATUTE |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
9 - OTHER MEDICAL ITEMS OR SERVICES
F - AMBULATORY SURGICAL CENTER (FACILITY USAGE FOR SURGICAL SERVICES)
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to C9073